Companies Backed by OrbiMed Advisors
7 companies in OrbiMed Advisors's investment portfolio.
Back to OrbiMed Advisors profileInvestment Thesis
“Healthcare-focused investment platform spanning all stages from seed through IPO in biotech, pharmaceuticals, and digital health.”
Portfolio Companies (5)
10x Genomics
10x Genomics makes instruments, consumables and software for single-cell and spatial biology research. It went public on Nasdaq (TXG) in September 2019 and reported $642.8 million of revenue for 2025.
Foundation Medicine
Foundation Medicine, Inc. is an American company based in Boston, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.
Guardant Health
Guardant Health develops blood-based liquid biopsy tests for cancer, led by Guardant360. It went public on Nasdaq as GH in October 2018 after raising about $550 million privately.
Moderna
Moderna, Inc. ( mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.
Veracyte
Veracyte is a South San Francisco genomic diagnostics company whose tests cover thyroid, prostate, breast and lung cancer. It went public on Nasdaq (VCYT) in October 2013 and reported $517M in revenue for 2025.
Other Investments (2)
Portfolio Analysis
OrbiMed Advisors has built a portfolio of 7 companies across 1 sector, including Biotech. Of these investments, 3 have achieved successful exits through acquisitions or IPOs, demonstrating the firm's track record of backing companies to meaningful outcomes.
The portfolio reflects investments across the IPO stage, showing OrbiMed Advisors's approach to supporting companies at a focused stage of development.
Frequently Asked Questions
How many companies has OrbiMed Advisors invested in?
OrbiMed Advisors has invested in 7+ companies across 1 different sectors. Of these, 3 have achieved successful exits through acquisitions or IPOs.
What sectors does OrbiMed Advisors invest in?
OrbiMed Advisors's portfolio spans Biotech. This diversification reflects the firm's broad investment thesis and sector expertise.
What stages does OrbiMed Advisors invest at?
OrbiMed Advisors invests across the IPO stage. Their portfolio includes companies at various points in their growth journey.
How many exits has OrbiMed Advisors had?
OrbiMed Advisors has had 3 portfolio companies achieve exits through acquisitions or IPOs. This track record of exits demonstrates the firm's ability to identify and support companies through successful outcomes.